Determinants of metabolic dysfunction associated steatotic liver disease and liver fibrosis in patients with type 2 diabetes mellitus: a cross-sectional study

BackgroundMetabolic dysfunction-associated steatotic liver disease (MASLD), formerly called non-alcoholic fatty liver disease (NAFLD), is today the leading cause of chronic liver conditions in the context of a global epidemic of obesity and metabolic disorders. Our study aims to determine the preval...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Soumaya Mrabet, Ghada Saad, Asma Ben cheikh, Mohamed Abu Awad, Imen Halloul, Raida Harbi, Meryam Eloillaf, Imen Akkari, Yosra Hasni, Elhem Ben Jazia
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2026-07-01
Colecção:	Frontiers in Medicine
Assuntos:	fibroscan hepatic steatosis liver fibrosis MASH MASLD type 2 diabetes mellitus
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fmed.2026.1863576/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!